E09.11 Drug or chemical induced diabetes mellitus with ketoacidosis with coma

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Ketoacidosis with Coma (ICD-10 Code: E09.11)

Summary

Drug or chemical induced diabetes mellitus with ketoacidosis with coma is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to the production of ketones and subsequent acidosis, resulting in loss of consciousness. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, leading to hyperglycemia, ketone accumulation, and coma.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia and ketone formation. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to ketoacidosis and coma due to the breakdown of fat for energy and subsequent acidosis.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Dosage and duration of exposure to the causative agent.
• Inadequate insulin production or increased insulin resistance.

Symptoms

• Increased thirst and frequent urination.
• Nausea, vomiting, and abdominal pain.
• Rapid breathing (Kussmaul respirations).
• Fruity-smelling breath.
• Confusion, drowsiness, or loss of consciousness (coma).
• Dehydration and dry mouth.

Diagnosis

Diagnosis involves confirming hyperglycemia, ketosis, and acidosis, along with identifying the causative drug or chemical. Blood tests measure glucose, ketones, and pH levels. Urine tests detect ketones, and a thorough medication or toxin exposure history is essential. Additional tests may rule out other causes of coma or metabolic disturbances.

Treatment Options

Treatment focuses on stabilizing blood sugar, correcting acidosis, and addressing the underlying cause. Intravenous fluids and insulin are administered to reduce glucose and ketones. Electrolyte imbalances are corrected, and the causative agent is discontinued or managed. Supportive care, including monitoring for complications, is critical.

Prognosis and Follow-Up

Prognosis depends on the speed of treatment and the severity of acidosis. Early intervention improves outcomes, but coma and organ damage may occur if untreated. Follow-up includes monitoring glucose levels, adjusting medications, and addressing the underlying cause to prevent recurrence.

Complications

• Severe dehydration and electrolyte imbalances.
• Organ failure (e.g., kidney or heart).
• Cerebral edema (rare but serious).
• Long-term neurological damage from coma.

Lifestyle & Prevention

• Avoid or monitor medications known to affect glucose metabolism.
• Maintain regular health check-ups to detect early signs of metabolic changes.
• Stay hydrated and follow a balanced diet to support glucose regulation.
• Educate patients on recognizing symptoms of hyperglycemia or ketoacidosis.

When to Seek Professional Help

Seek immediate medical attention if symptoms of hyperglycemia, ketosis, or coma occur, especially after starting new medications or exposure to chemicals. Prompt treatment is vital to prevent life-threatening complications.

Tips for Medical Coders

Document the specific drug or chemical exposure, the presence of ketoacidosis, and the coma to support accurate coding. Ensure clinical documentation aligns with the diagnosis, including lab results and treatment details, to justify the use of E09.11.